Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

BackgroundReimbursement policies influence access of patients to orphan drugs in the European countries.ObjectivesTo provide a comprehensive description of orphan drug reimbursement policies and to assess reimbursement decision-making process in the EU-CEE countries as well as the impact of the type...

Full description

Bibliographic Details
Main Authors: Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trąbka, Marcin Czech, Guenka Petrova, Manoela Manova, Alexandra Savova, Pero Draganić, Lenka Vostalová, Juraj Slabý, Agnes Männik, Kristóf Márky, Zinta Rugaja, Jolanta Gulbinovic, Tomas Tesar, Marian Sorin Paveliu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Pharmacology
Subjects:
orphan drug
reimbursement policy
Central and East Europe
European Medicine Agency
kappa coefficient of agreement
marketing authorisation
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00487/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00487/full

Similar Items